SFPQ-TFE3 reciprocally regulates mTORC1 and induces lineage plasticity in a mouse model of renal tumorigenesis
- Nat Commun. 2025 Oct 3;16(1):8822. doi: 10.1038/s41467-025-63885-2.
- 1. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. [email protected].
- 2. Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. [email protected].
- 3. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- 4. Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- 5. Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- 6. Division of Genomics and Transcriptomics, Kumamoto University, Kumamoto, Japan.
- 7. Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
- 8. Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
- 9. University of Maryland, School of Medicine, Baltimore, MD, USA.
- 10. Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- 11. Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
- 12. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. [email protected].
- 13. Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. [email protected].
- 14. Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. [email protected].
- # Contributed equally.
MiT/TFE gene fusions like SFPQ-TFE3 drive both epithelial (translocation RCC) and mesenchymal (PEComas) neoplasms. However, no mouse models for SFPQ-TFE3-related tumors exist and the underlying mechanisms of lineage plasticity remain unclear. Here, we demonstrate that constitutive murine renal expression of SFPQ-TFE3 disrupts kidney development with early neonatal renal failure and death, while post-natal induction induces infiltrative epithelioid tumors, that morphologically and transcriptionally resemble human PEComas, with strong activation of mTORC1 signaling via increased V-ATPase expression. Remarkably, SFPQ-TFE3 expression is sufficient to induce lineage plasticity, with down-regulation of the PAX2/PAX8 nephric lineage factors and tubular epithelial markers, and up-regulation of PEComa differentiation markers in transgenic mice, cell lines and human tRCC. mTOR inhibition downregulates SFPQ-TFE3 expression and rescues PAX8 expression and transcriptional activity in vitro. These data provide evidence of an epithelial cell-of-origin for TFE3-driven PEComas, highlighting a reciprocal role for SFPQ-TFE3 and mTOR in driving lineage plasticity in the kidney.